Aptiva Medical, a prominent provider of continuous glucose monitoring (CGM) systems, has successfully completed its acquisition of VeraMed Health on October 7, 2025. This strategic move significantly broadens Aptiva’s patient base and fortifies its referral and payor networks within the diabetes management sector.
The acquisition marks a pivotal moment for Aptiva Medical, allowing the company to advance its mission of providing comprehensive diabetes management solutions to patients nationwide. With this transaction, Aptiva aims to enhance its service offerings and streamline operations, ultimately improving patient outcomes.
Strengthening Leadership in Diabetes Care
Greenleaf Ventures, a healthcare-focused private investment firm based in Fort Lauderdale, played a crucial role in this acquisition. Led by Co-Founders Timothy Stocksdale and David Wallace, Greenleaf Ventures has a proven history of supporting and scaling successful healthcare companies, including Access Diabetic Supply and Comfort Medical.
Stocksdale and Wallace are particularly noted for their turnaround of Liberty Medical, which became the largest diabetic supply company in the U.S. after emerging from bankruptcy in 2014. Their experience and strategic vision continue to benefit Aptiva Medical as it seeks to solidify its leadership in the CGM distribution market.
According to Wallace, “This acquisition aligns perfectly with Aptiva Medical’s mission to build a leading, nationwide direct-to-patient CGM business.” He emphasized that the integration of VeraMed’s patient care systems will ensure continuity and enhance service quality for existing and new patients.
Comprehensive Patient Support
Aptiva Medical, headquartered in Fort Lauderdale, Florida, stands out as a national leader in the home delivery of CGMs, diabetes testing supplies, and specialty transplant medications. The company prides itself on providing end-to-end patient support, including prescription coordination, insurance billing, and convenient home delivery services.
By partnering with healthcare providers, payors, and patients, Aptiva aims to improve adherence to treatment protocols and overall health outcomes. The acquisition of VeraMed Health is expected to further enhance these capabilities, allowing the company to meet the growing demand for effective diabetes management solutions.
The integration process will focus on maintaining high levels of patient care and operational efficiency, ensuring that all patients experience a smooth transition. As Aptiva Medical continues to expand, its commitment to delivering superior service remains a top priority.
In conclusion, the acquisition of VeraMed Health represents a significant step for Aptiva Medical as it reinforces its position in the diabetes management landscape. This strategic growth initiative is set to benefit patients across the country, providing them with access to essential health resources and support.
